Full Text View
Tabular View
No Study Results Posted
Related Studies
Emergency Pharmacist Safety Study
This study is currently recruiting participants.
Verified by University of Rochester, September 2006
First Received: September 27, 2006   No Changes Posted
Sponsors and Collaborators: University of Rochester
Agency for Healthcare Research and Quality (AHRQ)
Information provided by: University of Rochester
ClinicalTrials.gov Identifier: NCT00382434
  Purpose

The Emergency Department (ED) is a unique environment in medicine, and many safety mechanisms used in other hospital settings cannot be applied in the ED. For example, clinical pharmacists have traditionally provided extra layers of protection to hospital inpatients by cross-checking provider orders for appropriate dosing, contraindications, and interactions. Because medications in the ED must be accessed immediately and are often one-time doses, the use of central pharmacy services would introduce an unacceptable delay to the administration of medication. Although some hospitals have programs in place in which a pharmacist responds to the ED for cardiac arrests or trauma team activations, few have reported programs which involve a clinical pharmacist assigned exclusively to the emergency department. Nonetheless, published reports have asserted that ED-based pharmacists can increase patient safety.

Although this concept appears logical, no study has attempted to show that these programs reduce potential adverse drug events in the ED. We propose to implement and optimize an ED Pharmacist (EDP) program as a safe practice intervention in a large ED. The hospital has provided funding for two permanent full time positions starting at the beginning of the award period. In the initial phase interviews of physicians, nurses, pharmacists, and patients will be conducted and the results will be used to optimize the EDP role. A large-scale chart review study will then be conducted to evaluate whether there is a reduction in frequency of potential and adverse drug events during times that the EDP is on duty. Staff perceptions of the effectiveness of this program will also be evaluated. The overall goal of this initiative is to create an effective EDP program that will decrease the rate of adverse drug events in ED patients, and to create a “toolkit” to facilitate the introduction of similar programs into other EDs. This toolkit will include a description of the formal, optimized role of the EDP, challenges and solutions in implementation, and evidence to support the efficacy of such a program.


Condition Intervention
Adverse Drug Event, Potential Adverse Drug Event, and Quality Measures
Procedure: presence of an emergency pharmacist in the ED

U.S. FDA Resources
Study Type: Observational
Study Design: Cross-Sectional, Random Sample, Retrospective/Prospective Study
Official Title: The ED Pharmacist as a Safety Measure in Emergency Medicine

Further study details as provided by University of Rochester:

Estimated Enrollment: 11385
  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • pediatric (less than 19), geriatric (>64), or critically ill (all ages)

Exclusion Criteria:

  • investigator involved or incomplete chart
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00382434

Contacts
Contact: Rollin J Fairbanks, MD, MS 585-273-3849 terry.fairbanks@rochester.edu

Locations
United States, New York
University of Rochester Medical Center Recruiting
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
Investigators
Principal Investigator: Rollin J Fairbanks, MD, MS University of Rochester
  More Information

Additional Information:
No publications provided

Study ID Numbers: 1U18HS015818, RSRB #11834
Study First Received: September 27, 2006
Last Updated: September 27, 2006
ClinicalTrials.gov Identifier: NCT00382434     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by University of Rochester:
emergency pharmacist
emergency medicine
emergency department
medical error
adverse event
pharmacist
patient safety

Study placed in the following topic categories:
Drug Toxicity
Poisoning
Disorders of Environmental Origin
Emergencies

Additional relevant MeSH terms:
Disease Attributes
Pathologic Processes
Drug Toxicity
Poisoning
Disorders of Environmental Origin
Emergencies

ClinicalTrials.gov processed this record on May 07, 2009